HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants
Consortia: CBDS
Felton JL, Cuthbertson D, Warnock M, Lohano K, Meah F, Wentworth JM, Sosenko J, Evans-Molina C; Type 1 Diabetes TrialNet Study Group.
Diabetologia. 2022 Jan;65(1):88-100. doi: 10.1007/s00125-021-05573-6. Epub 2021 Oct 12. PMID:34642772